Tsoukalas K, Ntanasis-Stathopoulos I, Andrikopoulou A, Tzartos J, Dimopoulos M, Gavriatopoulou M
J Clin Med. 2025; 14(2.
PMID: 39860369
PMC: 11765761.
DOI: 10.3390/jcm14020364.
Wang G, Chen M, Gao F, Guo M, Li M, He Q
Front Immunol. 2025; 15():1520493.
PMID: 39850901
PMC: 11754214.
DOI: 10.3389/fimmu.2024.1520493.
Huang P, Xu M
World J Clin Cases. 2023; 11(7):1586-1592.
PMID: 36926412
PMC: 10012000.
DOI: 10.12998/wjcc.v11.i7.1586.
Svarna A, Liontos M, Reppas G, Fiste O, Andrikopoulou A, Dimopoulos M
Gynecol Oncol Rep. 2023; 45:101136.
PMID: 36703705
PMC: 9871060.
DOI: 10.1016/j.gore.2023.101136.
Gibril M, Walters R
BMJ Case Rep. 2021; 14(5).
PMID: 33947671
PMC: 8098970.
DOI: 10.1136/bcr-2020-239389.
Antibodies as Diagnostic Targets and as Reagents for Diagnostics.
Trier N, Houen G
Antibodies (Basel). 2020; 9(2).
PMID: 32443407
PMC: 7345923.
DOI: 10.3390/antib9020015.
Cancer and motor neuron disease-causal or coincidental? Two contrasting cases.
Goodfellow J, Gorrie G, Leach V, Patel S, Mackay G
Neurol Sci. 2019; 40(7):1461-1463.
PMID: 30843116
DOI: 10.1007/s10072-019-03784-9.
The utility of anti-SOX2 antibodies for cancer prediction in patients with paraneoplastic neurological disorders.
Maddison P, Titulaer M, Verschuuren J, Gozzard P, Lang B, Irani S
J Neuroimmunol. 2018; 326:14-18.
PMID: 30445363
PMC: 6375907.
DOI: 10.1016/j.jneuroim.2018.11.003.
Diagnostic Approach to a Patient With Paraneoplastic Neurological Syndrome.
Mahta A, Vijayvergia N, Bhavsar T, Ward L
World J Oncol. 2017; 3(5):243-246.
PMID: 29147315
PMC: 5649905.
DOI: 10.4021/wjon571w.
Paraneoplastic limbic encephalitis with late-onset magnetic resonance imaging findings: A case report.
Tsunoda Y, Kiwamoto T, Homma S, Yabuuchi Y, Kitazawa H, Shiozawa T
Mol Clin Oncol. 2017; 7(2):259-262.
PMID: 28781798
PMC: 5532705.
DOI: 10.3892/mco.2017.1311.
Synchronous Adie's syndrome and type 1 antineuronal nuclear antibody (anti-Hu)-related paraneoplastic neurological syndromes as predictors of complete response in limited-stage small-cell lung cancer: A case report.
Sreter K, Barisic B, Barisic Kutija M, Kukulj S, Samarzija M
Mol Clin Oncol. 2017; 6(6):921-924.
PMID: 28588791
PMC: 5451861.
DOI: 10.3892/mco.2017.1248.
Paraneoplastic neurologic disorders in small cell lung carcinoma: A prospective study.
Gozzard P, Woodhall M, Chapman C, Nibber A, Waters P, Vincent A
Neurology. 2015; 85(3):235-9.
PMID: 26109714
PMC: 4516293.
DOI: 10.1212/WNL.0000000000001721.
Rare association of anti-hu antibody positive paraneoplastic neurological syndrome and transitional cell bladder carcinoma.
Lukacs S, Szabo N, Woodhams S
Case Rep Urol. 2013; 2012:724940.
PMID: 23320243
PMC: 3539377.
DOI: 10.1155/2012/724940.
Paraneoplastic neurological syndromes.
Graus F, Dalmau J
Curr Opin Neurol. 2012; 25(6):795-801.
PMID: 23041955
PMC: 3705179.
DOI: 10.1097/WCO.0b013e328359da15.
A 60-year-old woman with chorea and weight loss.
Vick A, Kraemer R, Morris J, Willett L, Centor R, Estrada C
J Gen Intern Med. 2011; 27(6):747-51.
PMID: 22143453
PMC: 3358395.
DOI: 10.1007/s11606-011-1928-x.
Opsoclonus-myoclonus syndrome and exaggerated startle response associated with small-cell lung cancer.
Sotirchos E, Ray Dorsey E, Tan I, Zee D
Mov Disord. 2011; 26(9):1769-70.
PMID: 21452255
PMC: 3139745.
DOI: 10.1002/mds.23626.
Paraneoplastic antigen Ma2 autoantibodies as specific blood biomarkers for detection of early recurrence of small intestine neuroendocrine tumors.
Cui T, Hurtig M, Elgue G, Li S, Veronesi G, Essaghir A
PLoS One. 2011; 5(12):e16010.
PMID: 21209860
PMC: 3012732.
DOI: 10.1371/journal.pone.0016010.